Kimberly R Jacob Arriola1, Tamara A Mason2, Kari Ann Bannon2, Carol Holmes2, Cecil Lamonte Powell2, Kandra Horne3, Ruth O'Regan3. 1. Rollins School of Public Health of Emory University, Department of Behavioral Sciences and Health Education, Atlanta, USA. Electronic address: kjacoba@sph.emory.edu. 2. Rollins School of Public Health of Emory University, Department of Behavioral Sciences and Health Education, Atlanta, USA. 3. Emory University School of Medicine and Winship Cancer Institute, Atlanta, USA.
Abstract
OBJECTIVE: Breast cancer incidence and mortality are declining due to improvements in early detection and treatment. One advance in treatment is the development of adjuvant endocrine therapy (AET) for women with hormone receptor positive breast cancer. Despite strong evidence linking AET to better health outcomes, AET adherence continues to be suboptimal. This study tests the hypothesis that patient beliefs about medication mediate the relationship between frequency of physician communication and AET adherence. METHODS: This cross-sectional study utilizes data from patient self-report and medical chart abstraction (N=200). Survey measures included frequency of physician communication, patient beliefs about medicine, AET adherence, and demographic characteristics. RESULTS: Necessity beliefs mediated the relationship between frequency of physician communication and medication adherence (necessity beliefs β=.18, p<.05; physician communication β=.13, p>.05). There was no evidence of medication concerns mediating the relationship between frequency of physician communication and medication adherence. CONCLUSION: More frequent physician communication that shapes what patients believe about AET importance may be associated with greater AET adherence; however, frequent physician communication that shapes patient concerns about side effects may not be associated with greater AET adherence. PRACTICE IMPLICATIONS: Research is needed to enhance understanding of the type of physician communication that is most consistently associated with patient beliefs about medication and AET adherence.
OBJECTIVE:Breast cancer incidence and mortality are declining due to improvements in early detection and treatment. One advance in treatment is the development of adjuvant endocrine therapy (AET) for women with hormone receptor positive breast cancer. Despite strong evidence linking AET to better health outcomes, AET adherence continues to be suboptimal. This study tests the hypothesis that patient beliefs about medication mediate the relationship between frequency of physician communication and AET adherence. METHODS: This cross-sectional study utilizes data from patient self-report and medical chart abstraction (N=200). Survey measures included frequency of physician communication, patient beliefs about medicine, AET adherence, and demographic characteristics. RESULTS: Necessity beliefs mediated the relationship between frequency of physician communication and medication adherence (necessity beliefs β=.18, p<.05; physician communication β=.13, p>.05). There was no evidence of medication concerns mediating the relationship between frequency of physician communication and medication adherence. CONCLUSION: More frequent physician communication that shapes what patients believe about AET importance may be associated with greater AET adherence; however, frequent physician communication that shapes patient concerns about side effects may not be associated with greater AET adherence. PRACTICE IMPLICATIONS: Research is needed to enhance understanding of the type of physician communication that is most consistently associated with patient beliefs about medication and AET adherence.
Authors: Shirley M Bluethmann; Caitlin C Murphy; Jasmin A Tiro; Michelle A Mollica; Sally W Vernon; Leona Kay Bartholomew Journal: Oncol Nurs Forum Date: 2017-05-01 Impact factor: 2.172
Authors: Gretchen Kimmick; Sara N Edmond; Hayden B Bosworth; Jeffrey Peppercorn; Paul K Marcom; Kimberly Blackwell; Francis J Keefe; Rebecca A Shelby Journal: Breast Date: 2015-07-16 Impact factor: 4.380
Authors: Joseph A Greer; Nicole Amoyal; Lauren Nisotel; Joel N Fishbein; James MacDonald; Jamie Stagl; Inga Lennes; Jennifer S Temel; Steven A Safren; William F Pirl Journal: Oncologist Date: 2016-02-26
Authors: Caitriona Cahir; Stephan U Dombrowski; Catherine M Kelly; M John Kennedy; Kathleen Bennett; Linda Sharp Journal: Support Care Cancer Date: 2015-03-07 Impact factor: 3.603
Authors: Jamie M Jacobs; Kathryn Post; Katina Massad; Nora K Horick; Emily A Walsh; Julia Cohn; Chelsea S Rapoport; Amy J Clara; Michael H Antoni; Steven A Safren; Ann H Partridge; Jeffrey M Peppercorn; Elyse R Park; Jennifer S Temel; Joseph A Greer Journal: Cancer Date: 2022-08-04 Impact factor: 6.921
Authors: Sue P Heiney; Pearman D Parker; Tisha M Felder; Swann Arp Adams; Omonefe O Omofuma; Jennifer M Hulett Journal: Breast Cancer Res Treat Date: 2018-11-01 Impact factor: 4.872
Authors: Alejandra Hurtado de Mendoza; Mark Cabling; Asma Dilawari; Jeanine W Turner; Nicole Fernández; Alesha Henderson; Qi Zhu; Sara Gómez; Vanessa B Sheppard Journal: Health Technol (Berl) Date: 2018-10-05
Authors: Leah K Lambert; Lynda G Balneaves; A Fuchsia Howard; Stephen L K Chia; Carolyn C Gotay Journal: Curr Oncol Date: 2021-04-09 Impact factor: 3.677